Total Payments
$4,162
2024 Payments
$1,216
Companies
29
Transactions
285
Medicare Patients
6,236
Medicare Billing
$186,517
Payment Breakdown by Category
Food & Beverage$4,162 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,162 | 285 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $734.86 | 55 | $0 (2024) |
| ABBVIE INC. | $607.91 | 51 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $579.14 | 23 | $0 (2024) |
| Novo Nordisk Inc | $545.43 | 41 | $0 (2024) |
| PFIZER INC. | $335.23 | 25 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $220.70 | 15 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $151.54 | 9 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $129.26 | 8 | $0 (2024) |
| Amarin Pharma Inc. | $116.85 | 8 | $0 (2022) |
| Amgen Inc. | $100.23 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,216 | 74 | Lilly USA, LLC ($300.21) |
| 2023 | $1,218 | 87 | ABBVIE INC. ($239.64) |
| 2022 | $1,241 | 87 | AstraZeneca Pharmaceuticals LP ($212.39) |
| 2021 | $486.95 | 37 | AbbVie Inc. ($122.11) |
All Payment Transactions
285 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: DIABETES | ||||||
| 11/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Cardio-renal | ||||||
| 11/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: VACCINES | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.07 | General |
| 11/01/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Cardio-renal | ||||||
| 10/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Biological | ||||||
| 10/16/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: PAIN | ||||||
| 09/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Inflammation | ||||||
| 09/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Biological | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Cardio-renal | ||||||
| 09/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: RESPIRATORY | ||||||
| 08/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Diabetes | ||||||
| 08/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Respiratory | ||||||
| 08/22/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: VACCINE | ||||||
| 08/20/2024 | Seqirus USA Inc | Flucelvax (Biological), Fluad | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Vaccines | ||||||
| 08/16/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,375 | 1,876 | $123,291 | $38,071 |
| 2022 | 30 | 2,213 | 3,278 | $207,131 | $71,989 |
| 2021 | 35 | 1,642 | 2,280 | $140,494 | $50,904 |
| 2020 | 27 | 1,006 | 1,426 | $84,223 | $25,552 |
Total Patients
6,236
Total Services
8,860
Medicare Billing
$186,517
Procedure Codes
114
All Medicare Procedures & Services
114 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 164 | 223 | $37,687 | $13,338 | 35.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 42 | 42 | $10,500 | $4,187 | 39.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 54 | 59 | $6,313 | $2,728 | 43.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 190 | 319 | $2,818 | $2,588 | 91.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 146 | 235 | $16,685 | $2,424 | 14.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 99 | 136 | $9,656 | $2,239 | 23.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 110 | 140 | $8,820 | $1,758 | 19.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 171 | 229 | $7,557 | $1,737 | 23.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 26 | 30 | $2,100 | $1,508 | 71.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 22 | 22 | $2,178 | $1,398 | 64.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 21 | 46 | $1,840 | $746.12 | 40.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 62 | 78 | $3,432 | $717.14 | 20.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 19 | 23 | $2,829 | $619.01 | 21.9% |
| 82550 | Creatine kinase (cardiac enzyme) level, total | Office | 2023 | 67 | 86 | $2,494 | $535.92 | 21.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 25 | 29 | $2,842 | $427.85 | 15.1% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 63 | 77 | $1,155 | $227.76 | 19.7% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 12 | 12 | $984.00 | $227.04 | 23.1% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 32 | 33 | $990.00 | $178.20 | 18.0% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 12 | 12 | $744.00 | $160.32 | 21.5% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 12 | 17 | $765.00 | $150.28 | 19.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 15 | $525.00 | $94.49 | 18.0% |
| 83540 | Iron level | Office | 2023 | 13 | 13 | $377.00 | $82.42 | 21.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 212 | 317 | $53,573 | $23,556 | 44.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 160 | 204 | $21,828 | $10,522 | 48.2% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 107 | 118 | $8,260 | $5,828 | 70.6% |
About Lauren Vanderburg
Lauren Vanderburg is a Nurse Practitioner healthcare provider based in Southaven, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/28/2017. The National Provider Identifier (NPI) number assigned to this provider is 1669907424.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lauren Vanderburg has received a total of $4,162 in payments from pharmaceutical and medical device companies, with $1,216 received in 2024. These payments were reported across 285 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($4,162).
As a Medicare-enrolled provider, Vanderburg has provided services to 6,236 Medicare beneficiaries, totaling 8,860 services with total Medicare billing of $186,517. Data is available for 4 years (2020–2023), covering 114 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Southaven, MS
- Active Since 04/28/2017
- Last Updated 02/21/2020
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1669907424
Products in Payments
- MOUNJARO (Drug) $529.82
- JARDIANCE (Drug) $266.88
- VRAYLAR (Drug) $266.76
- FARXIGA (Drug) $240.28
- NURTEC ODT (Drug) $233.83
- UBRELVY (Drug) $165.59
- Kerendia (Drug) $151.54
- Saxenda (Drug) $138.00
- AIRSUPRA (Drug) $123.04
- Vascepa (Drug) $116.85
- PREVNAR 20 (Biological) $116.13
- Rybelsus (Drug) $111.45
- Ozempic (Drug) $110.24
- QULIPTA (Drug) $104.19
- TRINTELLIX (Drug) $100.48
- BREZTRI (Drug) $89.59
- TRULICITY (Drug) $84.80
- TRELEGY ELLIPTA (Drug) $79.78
- Otezla (Drug) $78.66
- COMIRNATY (Biological) $65.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Southaven
Mrs. Mary Tullos, Np-C, NP-C
Nurse Practitioner — Payments: $5,083
Nurse Practitioner $5,083
Paula Miller, Aprn, APRN
Nurse Practitioner — Payments: $5,060
Nurse Practitioner $5,060
Catherine Smith, Apn, APN
Nurse Practitioner — Payments: $4,540
Nurse Practitioner $4,540
Michaeline Bailey
Nurse Practitioner — Payments: $3,932
Nurse Practitioner $3,932
Olamide Adeleye, Np, NP
Nurse Practitioner — Payments: $2,821
Nurse Practitioner $2,821
Rena Montgomery, Apn, APN
Nurse Practitioner — Payments: $2,769
Nurse Practitioner $2,769